Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Preceptorship on Immuno-Oncology 2022: Zurich, December

Session 7 - Audience Cases

Participant Clinical Case Discussion: Tebentafusp Response as an Example of Promising New Therapies on the Horizon (Tebentafusp)

Date

17 Dec 2022

Session

Session 7 - Audience Cases

Topics

Immunotherapy

Tumour Site

Presenters

M. Portu Grivé, ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.